Recent findings highlighted in Anesthesiology News emphasize the potential of Suzetrigine in significantly reducing the need for opioids in postoperative care. This groundbreaking research reveals that patients administered Suzetrigine experienced less postoperative pain and consequently required fewer opioid medications. This study could herald a major shift in pain management protocols, addressing the ongoing opioid crisis by minimizing opioid dependency after surgeries. The detailed analysis presented underscores Suzetrigine’s efficacy and safety profile, making it an attractive option for clinicians seeking alternative pain management solutions. With its promising results, Suzetrigine stands out as a potential game-changer in reducing the risks associated with opioid use, offering hope for improved patient recovery and well-being. These insights not only provide important implications for patient care but also for future research directions in pain management therapies.
Anesthesiology NewsNew data shows Nigeria Tops Africa in Spam Call Volume
May 7, 2026
A recent report by Truecaller reveals that Nigeria is leading the African continent in the number of spam calls received. According to the data, the